504399-93-3 Usage
Class
Pyrimidine derivatives
Belongs to a group of chemical compounds that have a pyrimidine ring in their structure.
Derivative of Ethanol
Modified from the basic structure of ethanol (an alcohol) by attaching additional functional groups.
Pyrimidine Ring
A heterocyclic aromatic ring structure consisting of four atoms (two carbon and two nitrogen) that is part of the compound's structure.
Phenyl Group (-C6H5)
A flat, unsaturated ring of six carbon atoms with alternating single and double bonds, attached to the pyrimidine ring.
Amino Group (-NH2)
A nitrogen atom with two hydrogen atoms attached, contributing to the compound's structure and properties.
Potential Applications
Pharmaceutical industry
Possible use in drug development targeting specific receptors or enzymes, but requires further research to understand its properties and potential uses.
Check Digit Verification of cas no
The CAS Registry Mumber 504399-93-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,4,3,9 and 9 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 504399-93:
(8*5)+(7*0)+(6*4)+(5*3)+(4*9)+(3*9)+(2*9)+(1*3)=163
163 % 10 = 3
So 504399-93-3 is a valid CAS Registry Number.
InChI:InChI=1/C13H15N3O/c1-10-9-12(14-7-8-17)16-13(15-10)11-5-3-2-4-6-11/h2-6,9,17H,7-8H2,1H3,(H,14,15,16)
504399-93-3Relevant academic research and scientific papers
Synthesis and structure-activity relationship of 4-amino-2-phenylpyrimidine derivatives as a series of novel GPR119 agonists
Negoro, Kenji,Yonetoku, Yasuhiro,Maruyama, Tatsuya,Yoshida, Shigeru,Takeuchi, Makoto,Ohta, Mitsuaki
, p. 2369 - 2375 (2012/05/05)
Through preparation and examination of a series of novel 4-amino-2-phenylpyrimidine derivatives as agonists for GPR119, we identified 2-(4-bromophenyl)-6-methyl-N-[2-(1-oxidopyridin-3-yl)ethyl]pyrimidin-4-amine (9t). Compound 9t improved glucose tolerance in mice following oral administration and showed good pharmacokinetic profiles in rats.
